These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8803525)

  • 1. Effect of food intake on pharmacokinetics and effects of a new thromboxane A2 receptor antagonist, S-1452.
    Fujimura A; Shiga T; Kumagai Y; Ohashi K; Ebihara A; Kotegawa T
    Eur J Clin Pharmacol; 1996; 50(4):311-4. PubMed ID: 8803525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a new thromboxane A2 receptor antagonist, S-1452, and its effect on platelet aggregation in healthy volunteers.
    Fujimura A; Shiga T; Kumagai Y; Ohashi K; Ebihara A; Kotegawa T
    J Clin Pharmacol; 1996 May; 36(5):409-13. PubMed ID: 8739019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].
    Kakushi H; Shike T; Uchida K
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment at night with S-1452, a thromboxane A2 receptor antagonist, on the morning rise in platelet aggregation.
    Fujimura A; Kumagai K; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1992; 43(5):501-5. PubMed ID: 1483486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent inhibition by glyceryl trinitrate of platelet aggregation caused by U46619 (a thromboxane/endoperoxide receptor agonist).
    Kampf G; Ritter JM
    Br J Clin Pharmacol; 1994 Jul; 38(1):80-2. PubMed ID: 7946941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers.
    Uematsu T; Nagashima S; Mizuno A; Hirano K; Nakashima M
    J Clin Pharmacol; 1991 Sep; 31(9):815-22. PubMed ID: 1839540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol for inhalation.
    Takenaga M; Nakagawa T; Igarashi R; Mizushima Y
    J Drug Target; 1993; 1(4):293-301. PubMed ID: 8069571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
    Turini ME; Holub BJ
    Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
    Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M
    J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):765-77. PubMed ID: 8681409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of ONO-3708 and S-145 on shape change and aggregation of rabbit platelets induced by STA2.
    Li BY; Qiao GF; Sun JP; Gao YR; Li WH
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):345-8. PubMed ID: 9812720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
    Hanasaki K; Nagasaki T; Arita H
    Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and pharmacology of 3-substituted sodium azulene-1-sulfonates and related compounds: non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T; Yokota M; Wakabayashi S; Kosakai K; Yanagisawa T
    J Med Chem; 1993 Apr; 36(7):791-800. PubMed ID: 8464032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.